|
"shan yan shen"的相关文件
显示项目 21-30 / 111 (共12页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
| 國立成功大學 |
2016-05 |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
|
Chiang, Nai-Jung; Hsu, Chiun; Chen, Jen-Shi; Tsou, Hsiao-Hui; Shen, Ying-Ying; Chao, Yee; Chen, Ming-Huang; Yeh, Ta-Sen; Shan, Yan-Shen; Huang, Shiu-Feng; Chen, Li-Tzong |
| 國立成功大學 |
2016-03-22 |
An increase in galectin-3 causes cellular unresponsiveness to IFN-gamma-induced signal transduction and growth inhibition in gastric cancer cells
|
Tseng, Po-Chun; Chen, Chia-Ling; Shan, Yan-Shen; Lin, Chiou-Feng |
| 國立成功大學 |
2016-02-06 |
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
|
Wang-Gillam, Andrea;Li, Chung-Pin;Bodoky, Gyoergy;Dean, Andrew;Shan, Yan-Shen;Jameson, Gayle;Macarulla, Teresa;Lee, Kyung-Hun;Cunningham, David;Blanc, Jean F.;Hubner, Richard A.;Chiu, Chang-Fang;Schwartsmann, Gilberto;Siveke, Jens T.;Braiteh, Fadi;Moyo, Victor;Belanger, Bruce;Dhindsa, Navreet;Bayever, Eliel;Von Hoff, Daniel D.;Chen, Li-Tzong |
| 國立成功大學 |
2016-02-01 |
Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC).
|
Chiang, Nai-Jung; Tsai, Kelvin K.; Chen, Jen-Shi; Yang, Shih-Hung; Hsu, Chiun; Shan, Yan-Shen; Chen, Li-Tzong |
| 國立成功大學 |
2016-02-01 |
Results of Phase II trial of AUY922, a novel heat shock protein inhibitor in patients with metastatic gastrointestinal stromal tumor (GIST) and imatinib and sunitinib therapy.
|
Chiang, Nai-Jung;Yeh, Kun-Huei;Chiu, Chang-Fang;Chen, Jen-Shi;Yen, Chueh-Chuan;Lee, Kuan-Der;Lin, Yu-Lin;Bai, Li-Yuan;Chen, Ming-Huang;Lin, Jen-Shi;Yang, Youngsen;Rau, Kun-Ming;Hsiao, Hui-Hua;Shan, Yan-Shen;Chen, Li-Tzong |
| 國立成功大學 |
2016-01 |
A Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma The TCOG 3211 Clinical Trial
|
Chen, Ming-Huang; Lin, Johnson; Hsiao, Chin-Fu; Shan, Yan-Shen; Chen, Yeu-Chin; Chen, Li-Tzong; Liu, Tsang-Wu; Li, Chung-Pin; Chao, Yee |
| 國立成功大學 |
2016-01 |
Investigating the Association Between Periodontal Disease and Risk of Pancreatic Cancer
|
Chang, Jeffrey S.; Tsai, Chia-Rung; Chen, Li-Tzong; Shan, Yan-Shen |
| 國立成功大學 |
2016 |
Development of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02) in the management of metastatic pancreatic cancer
|
Chiang, Nai-Jung; Chang, Jang-Yang; Shan, Yan-Shen; Chen, Li-Tzong |
| 國立成功大學 |
2016 |
Expanded analyses of NAPOLI-1: Phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
|
Siveke, Jens T.;Chen, Li-Tzong;Von Hoff, Daniel D;Li, Chung-Pin;Wang-Gillam, Andrew;Bodoky, Gyorgy;Dean, Andrew;Shan, Yan-Shen;Jameson, Gayel S;Macarulla, T.;Lee, K-H;Cunningham, D.;Blanc, J-F;Hubner, R. A.;Chiu, C-F;Schwartsmann, G.;Braiteh, F.;Moyo, V.;Belanger, B.;Bayever, E. |
| 國立臺灣大學 |
2016 |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
|
Chiang, Nai-Jung; Hsu, Chiun; Chen, Jen-Shi; Tsou, Hsiao-Hui; Shen, Ying-Ying; Chao, Yee; Chen, Ming-Huang; Yeh, Ta-Sen; Shan, Yan-Shen; Huang, Shiu-Feng; Chen, Li-Tzong; 許駿 |
显示项目 21-30 / 111 (共12页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
|
